These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 9039966)

  • 21. Estrogen effects on platelet-activating factor and platelet-activating factor acetylhydrolase activity in rat uterus during the late stages of pregnancy.
    Li L; Yasuda K; Matsubara T; Okada H; Nakajima T; Sanezumi M; Kanzaki H
    Prostaglandins Other Lipid Mediat; 1999 Jun; 57(4):219-30. PubMed ID: 10402216
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Platelet aggregatory response to platelet activating factor (PAF), ex vivo, and PAF-acetylhydrolase activity in patients with unstable angina: effect of c7E3 Fab (abciximab) therapy.
    Tselepis AD; Goudevenos JA; Tambaki AP; Michalis L; Stroumbis CS; Tsoukatos DC; Elisaf M; Sideris DA
    Cardiovasc Res; 1999 Jul; 43(1):183-91. PubMed ID: 10536703
    [TBL] [Abstract][Full Text] [Related]  

  • 23. PAF-acetylhydrolase activity of Lp(a) before and during Cu(2+)-induced oxidative modification in vitro.
    Karabina SA; Elisaf MC; Goudevenos J; Siamopoulos KC; Sideris D; Tselepis AD
    Atherosclerosis; 1996 Aug; 125(1):121-34. PubMed ID: 8831934
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Plasma platelet-activating factor acetylhydrolase activity in human immunodeficiency virus infection and the acquired immunodeficiency syndrome.
    Khovidhunkit W; Memon RA; Shigenaga JK; Pang M; Schambelan M; Mulligan K; Feingold KR; Grunfeld C
    Metabolism; 1999 Dec; 48(12):1524-31. PubMed ID: 10599983
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The central role of PAF in necrotizing enterocolitis development.
    Muguruma K; Gray PW; Tjoelker LW; Johnston JM
    Adv Exp Med Biol; 1997; 407():379-82. PubMed ID: 9321979
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Partial purification and localization of platelet-activating factor acetylhydrolase from bovine seminal plasma.
    Hough SR; Parks JE
    J Androl; 1997; 18(5):540-8. PubMed ID: 9349753
    [TBL] [Abstract][Full Text] [Related]  

  • 27. In vivo regulation of plasma platelet-activating factor acetylhydrolase during the acute phase response.
    Memon RA; Fuller J; Moser AH; Feingold KR; Grunfeld C
    Am J Physiol; 1999 Jul; 277(1):R94-103. PubMed ID: 10409262
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Platelet-activating factor acetylhydrolase in term and preterm human milk: a preliminary report.
    Moya FR; Eguchi H; Zhao B; Furukawa M; Sfeir J; Osorio M; Ogawa Y; Johnston JM
    J Pediatr Gastroenterol Nutr; 1994 Aug; 19(2):236-9. PubMed ID: 7815247
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Depressed plasma platelet-activating factor acetylhydrolase in patients presenting with acute myocardial infarction.
    Serebruany VL; Gurbel PA; Murugesan SR; Lowry DR; Sturm E; Svetlov SI
    Cardiology; 1998 Oct; 90(2):127-30. PubMed ID: 9778550
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Plasma and Lp(a)-associated PAF-acetylhydrolase activity in uremic patients undergoing different dialysis procedures.
    Milionis HJ; Elisaf MS; Karabina SA; Bairaktari E; Tselepis AD; Siamopoulos KC
    Kidney Int; 1999 Dec; 56(6):2276-85. PubMed ID: 10594806
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The mouse plasma PAF acetylhydrolase: I. Characterization and properties.
    Tsaoussis V; Vakirtzi-Lemonias C
    J Lipid Mediat Cell Signal; 1994 May; 9(3):301-15. PubMed ID: 7921789
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Platelet activating factor-acetylhydrolase activity following chorionic villus sampling and amniocentesis.
    Saleh AA; Pryde PG; Isada NB; Johnson MP; Evans MI; Sokol RJ; Zhao B; Johnston JM
    J Soc Gynecol Investig; 1994; 1(2):135-7. PubMed ID: 9419761
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The effect of exenatide (a GLP-1 analog) and sitagliptin (a DPP-4 inhibitor) on plasma platelet-activating factor acetylhydrolase (PAF-AH) activity and concentration in normal and fructose-fed rats.
    Wójcicka G; Zaręba M; Warpas A; Jamroz-Wiśniewska A; Rusek M; Czechowska G; Bełtowski J
    Eur J Pharmacol; 2019 May; 850():180-189. PubMed ID: 30768981
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Atorvastatin preferentially reduces LDL-associated platelet-activating factor acetylhydrolase activity in dyslipidemias of type IIA and type IIB.
    Tsimihodimos V; Karabina SA; Tambaki AP; Bairaktari E; Goudevenos JA; Chapman MJ; Elisaf M; Tselepis AD
    Arterioscler Thromb Vasc Biol; 2002 Feb; 22(2):306-11. PubMed ID: 11834533
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Increased activity of platelet-activating factor acetylhydrolase in low-density lipoprotein subfractions induces enhanced lysophosphatidylcholine production during oxidation in patients with heterozygous familial hypercholesterolaemia.
    Karabina SA; Elisaf M; Bairaktari E; Tzallas C; Siamopoulos KC; Tselepis AD
    Eur J Clin Invest; 1997 Jul; 27(7):595-602. PubMed ID: 9263748
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Adenovirus-mediated gene transfer of human platelet-activating factor-acetylhydrolase prevents injury-induced neointima formation and reduces spontaneous atherosclerosis in apolipoprotein E-deficient mice.
    Quarck R; De Geest B; Stengel D; Mertens A; Lox M; Theilmeier G; Michiels C; Raes M; Bult H; Collen D; Van Veldhoven P; Ninio E; Holvoet P
    Circulation; 2001 May; 103(20):2495-500. PubMed ID: 11369691
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Correlations between plasma platelet-activating factor acetylhydrolase (PAF-AH) activity and PAF-AH genotype, age, and atherosclerosis in a Japanese population.
    Yamada Y; Yoshida H; Ichihara S; Imaizumi T; Satoh K; Yokota M
    Atherosclerosis; 2000 May; 150(1):209-16. PubMed ID: 10781653
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Effects of estrogen and progestin on platelet-activating factor acetylhydrolase].
    Takashima M; Yasuda K; Umesaki K; Nakajima T; Sawaragi I
    Nihon Sanka Fujinka Gakkai Zasshi; 1994 Jun; 46(6):481-8. PubMed ID: 8040619
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Thyroid substitution therapy induces high-density lipoprotein-associated platelet-activating factor-acetylhydrolase in patients with subclinical hypothyroidism: a potential antiatherogenic effect.
    Milionis HJ; Tambaki AP; Kanioglou CN; Elisaf MS; Tselepis AD; Tsatsoulis A
    Thyroid; 2005 May; 15(5):455-60. PubMed ID: 15929667
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Relative sensitivities of plasma lecithin:cholesterol acyltransferase, platelet-activating factor acetylhydrolase, and paraoxonase to in vitro gas-phase cigarette smoke exposure.
    Bielicki JK; Knoff LJ; Tribble DL; Forte TM
    Atherosclerosis; 2001 Mar; 155(1):71-8. PubMed ID: 11223428
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.